News
08-21-2026, 07:10 AM
Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant subtypes of breast cancer, accounting for 15-20% of all cases.
More... (https://www.news-medical.net/news/20260821/Multifunctional-nanoplatform-addresses-three-key-barriers-to-effective-TNBC-immunotherapy.aspx)
More... (https://www.news-medical.net/news/20260821/Multifunctional-nanoplatform-addresses-three-key-barriers-to-effective-TNBC-immunotherapy.aspx)